Leading vitamin K2 player, NattoPharma, welcomed industry veteran Jeff Lind as its Vice President of Sales, Americas.
Lind joins NattoPharma from Natreon, Inc., where he served as the Vice President of Sales and Marketing. Prior to Natreon, he led Frutarom US, Inc.’s North American Health Business Unit, and served as the CEO with Sabinsa Corporation.
“Jeff is a proven sales leader who is greatly respected within our industry. Not only is his technical understanding of ingredients unsurpassed, but he brings a fresh take on the global market that will create new opportunities for NattoPharma,” says Dan Rosenbaum, NattoPharma CEO.
“With both current and new customers, Jeff is well-positioned to communicate the compelling science behind our MenaQ7, the importance of partnering with the highest quality MK-7 provider, and the tremendous commercial opportunity that MenaQ7 represents to our customers.”